BYD has described BYD Care as a subsidiary business involved in manufacturing PPE to support healthcare providers, communities, and individuals during the pandemic.

Background

Prior to 2020, BYD was primarily recognised for its rechargeable batteries, automobiles, electric buses, electronics, and renewable energy technologies. The onset of the COVID-19 pandemic created an unprecedented worldwide shortage of masks and other PPE. In response, BYD redirected a portion of its manufacturing and engineering capacity toward medical protection equipment.

According to company accounts, this effort began in late January 2020. A special task force comprising more than 3,000 engineers was established to develop mask-production equipment and manufacturing processes. BYD stated that its engineers completed the development of mask-production machinery in approximately seven days, significantly faster than the typical 15–30 day development cycle. Production subsequently commenced at BYD’s industrial facilities in Shenzhen.

Rapid expansion

BYD’s manufacturing scale expanded rapidly. The company reported that its mask production operation eventually reached a capacity of approximately 50 million masks per day, making it the world’s largest manufacturer of respiratory masks at that time. The resulting products were marketed under both the BYD and BYD CARE trademarks. This expansion represented a notable instance of an industrial company creating a major healthcare manufacturing operation by repurposing existing engineering, automation, and supply chain capabilities.

BYD CARE was primarily associated with PPE and respiratory protection.

N95 respirators

A key product line was the N95 particulate respirator. U.S. government medical device databases identify BYD CARE DF1122 as an N95 healthcare particulate respirator and surgical mask manufactured by BYD Precision Manufacture Co., Ltd.2 BYD also produced the DE2322 NIOSH N95 respirator, which FDA records identify as a BYD CARE product manufactured by BYD Precision Manufacture Co., Ltd.3

KN95 respirators

The brand also marketed KN95 respiratory protection products, particularly in markets where the Chinese KN95 standard was applicable.

Surgical masks

BYD CARE was used for single-use surgical masks. The FDA’s Global Unique Device Identification Database (GUDID) contains listings for disposable masks under the brand, including model FE2311, described as a single-use face mask with specified bacterial and particulate filtration ratings.2

Gloves and other PPE

Medical device registrations for BYD Care include nitrile examination and treatment gloves. The GUDID database lists multiple BYD CARE device records covering masks, respirators, and nitrile gloves.2 During the pandemic, BYD also produced or supplied other protective items such as hand sanitiser, donating PPE and sanitiser to healthcare organisations, transit agencies, and first responders.

A defining characteristic of BYD CARE was its industrial-scale manufacturing approach. BYD was not originally a conventional medical device company; however, its existing expertise in automation, battery manufacturing, electronics, precision manufacturing, supply chain management, industrial equipment, materials engineering, and large-scale production enabled the rapid construction of mask-production equipment.

BYD engineers designed and manufactured mask-production machinery internally rather than relying entirely on external suppliers. This capability allowed the company to transition from concept to production quickly during the early stages of the pandemic. This narrative positioned BYD Care as an industrial technology company utilising its manufacturing ecosystem to address a public health supply shortage.

BYD CARE products entered regulated healthcare markets, particularly in the United States. U.S. GUDID records identify BYD CARE respiratory and surgical mask products as medical devices.2 BYD announced that specific N95 products received NIOSH approval, while surgical masks were marketed with applicable U.S. regulatory clearances during the pandemic.3

Certification applies to specific models, configurations, and manufacturers rather than the brand as a whole. For example, FDA records specifically identify the DE2322 model as a NIOSH N95 particulate respirator.3

At the height of the pandemic, BYD Care products were distributed internationally. BYD stated that its PPE products were available globally and sold through U.S. retailers including Costco and Office Depot during 2020. The company also supplied institutional customers such as hospitals, healthcare providers, first responders, government agencies, schools, and transit authorities.

BYD’s North American operations participated in large-scale government supply programs. A 2020 U.S. federal court record describes BYD’s production of approximately 50 million masks per day and its supply of N95 and KN95 products under the BYD and BYD Care marks.4

BYD utilised its production capacity for substantial donations of masks and other protective equipment during the pandemic. For instance, the company announced a donation of 16 million masks to support communities in Africa during Africa Mask Week in 2020. BYD’s U.S. operations also reported donating more than $1 million worth of medical supplies, including PPE and hand sanitiser, to transit agencies and first responders. These activities helped establish the brand’s public image around the themes of protection, manufacturing scale, and social responsibility.

Due to extraordinarily high demand for N95 and other respirators in 2020, counterfeit and falsely labelled products became a significant issue. BYD publicly warned customers about counterfeit products claiming to be manufactured by the company and pursued litigation against parties accused of selling or advertising fake BYD masks.4 The company emphasised that counterfeit products posed particular dangers to healthcare workers and first responders relying on them for respiratory protection. BYD subsequently established a Product Authenticity Verification Program to assist customers and organisations in verifying genuine BYD CARE products and suppliers.

Official medical device databases provide insight into the scope of BYD CARE. The U.S. AccessGUDID database contains multiple records under the brand involving several BYD-related entities, including BYD Precision Manufacture Co., Ltd., BYD Auto Industry Company Limited, and Global Healthcare Product Solutions, LLC.2 These records cover surgical masks, face masks, respirators, and nitrile examination gloves, indicating that BYD CARE was associated with identifiable medical device products and manufacturers in regulatory systems rather than serving merely as a marketing label.

The BYD CARE brand functioned as an extension of BYD’s broader corporate philosophy of “Build Your Dreams,” which historically focused on technology, manufacturing, and innovation. BYD Care applied this industrial philosophy to healthcare through large-scale technology manufacturing. Rather than positioning itself as a traditional pharmaceutical or medical care company, BYD Care was fundamentally a manufacturing-driven healthcare brand. Its primary competitive characteristics included manufacturing capacity, rapid scale-up, engineering capability, supply chain integration, broad PPE production, regulatory compliance for specific products, and leverage of BYD’s global corporate infrastructure.

It is necessary to distinguish BYD CARE from BYD Auto. BYD is a large corporate group with businesses spanning multiple technological sectors. BYD Care was associated specifically with healthcare and PPE activities during the COVID-19 crisis. The relationship can be understood hierarchically: BYD Group oversees healthcare and PPE operations, which produce BYD CARE branded N95/KN95 respirators, surgical masks, disposable masks, gloves, and other protective products. The specific corporate entity responsible for manufacturing or distributing a particular product may vary by market and product type; consequently, “BYD Care” does not automatically refer to a single worldwide legal corporation.

While BYD Care was strongly associated with the PPE expansion of 2020–2021, the name no longer represents a single globally standardised healthcare business. Current regulatory databases continue to contain BYD CARE product records with active commercial distribution information.2 However, BYD now also uses the name BYD Care for unrelated automotive services in certain markets. For example, BYD’s UK website uses BYD Care for an electric vehicle insurance comparison and service platform operated with bolttech.1 Similarly, some markets use the term for vehicle maintenance and roadside assistance packages. Therefore, the term “BYD Care” requires contextual verification to determine whether it refers to medical PPE or automotive services.

From a business history perspective, BYD CARE represents a significant example of industrial diversification during the COVID-19 pandemic. BYD transitioned from being primarily associated with vehicles, batteries, and electronics to becoming one of the world’s largest mask manufacturers within months. This case illustrates key characteristics of BYD’s industrial model:

• Vertical integration: Significant internal manufacturing and engineering capabilities.
• Rapid industrial conversion: Ability to redirect existing factories, engineers, and production systems toward new product categories.
• Economies of scale: Capacity to manufacture enormous quantities of PPE once production lines were established.
• Global distribution: Utilisation of international presence for medical product distribution channels.
• Brand leverage: Application of established corporate recognition to a new healthcare product line.

Brand strengths

• Manufacturing credibility: Demonstrated enormous production capacity.
• Engineering heritage: Benefited from existing technology and manufacturing expertise.
• Global reach: Leveraged pre-existing international infrastructure.
• Regulatory presence: Specific products entered official medical device systems and NIOSH-regulated pathways.2
• Pandemic relevance: Emerged during a period of exceptionally high demand for respiratory protection.

Limitations and considerations

• Brand versus certification: BYD CARE is a brand name, not a universal certification standard. Buyers must verify exact model numbers, manufacturers, regulatory status, and applicable standards.
• Product availability: Products widely distributed during 2020–2021 may no longer be available through the same channels.
• Legal entities: Manufacturing and distribution involve different BYD-related companies depending on the country and product.2
• Name ambiguity: The concurrent use of “BYD Care” for automotive insurance and services necessitates careful distinction when researching the brand.1

1. An insurance solution designed for electrified vehicles | BYD Care
2. AccessGUDID – DEVICE: BYD CARE (00860003645154)
3. MAUDE Adverse Event Report: BYD PRECISION MANUFACTURE CO., LTD. BYD CARE DE2322 NIOSH N95 PARTICULATE RESPIRATOR; RESPIRATOR, SURGICAL
4. BYD Company Ltd et al v. Alexander Khazai et al, No. 2:2020cv05530 – Document 29 (C.D. Cal. 2020) :: Justia